Blueprint Medicines CorpBPMC

Market cap
$8.4B
P/E ratio
Dec 31,
2015
Dec 31,
2016
Dec 31,
2017
Dec 31,
2018
Dec 31,
2019
Dec 31,
2020
Dec 31,
2021
Dec 31,
2022
Dec 31,
2023
Dec 31,
2024
Cash and cash equivalents163524006811468521012071102
Marketable securities-162273426370187267825639513
Accounts receivable----1725244376
Unbilled accounts receivable34--2318121302
Inventory-----922302114
Prepaid expenses and other current assets43126102218353336
Total current assets1702206865005179285541,047808743
Marketable securities-54--6467855813357248
Property and equipment, net762430383431334237
Operating Lease, Right-of-Use Asset----736890827464
Restricted cash---555551012
Equity investment-------282829
Other assets111610615223148
Total assets1792837165407081,7181,2521,3501,0491,180
Accounts payable2243548357
Accrued expenses612315289106122131128133
Operating Lease, Liability, Current----788111213
Current portion of deferred revenue---461312512
Other Long-Term Debt, Current-------173962
Secured Debt, Current-------173044
Total current liabilities19294360106131150183215261
Operating Lease, Liability, Noncurrent----8982103938269
Deferred revenue, net of current portion---434029251458
Other Long-Term Debt, Noncurrent-------413402194
Term loan, net of current portion-------122209343
Other long-term liabilities00008731067
Total liabilities---121243248281835919881
Common Stock, Value, Issued0000000000
Additional paid-in capital2794219801,0171,4122,1072,2502,3582,4742,709
Accumulated other comprehensive loss--0-0-0-3-5-4-10-3-4
Accumulated deficit-135-207-356-598-945-631-1,275-1,833-2,340-2,407
Total stockholders' equity1442136244194641,470971515131299
Total liabilities and stockholders' equity1792837165407081,7181,2521,3501,0491,180